Thorsten Brenner

发表

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

Francisco J. Medrano, S. Brunak, V. Moreno, 2022, Human molecular genetics.

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Impaired ketogenesis ties metabolism to T cell dysfunction in COVID-19

M. Netea, T. Welte, C. Putensen, 2022, Nature.

Critically Ill COVID-19 Patients Show Reduced Point of Care-Measured Butyrylcholinesterase Activity—A Prospective, Monocentric Observational Study

Aleksandar R. Zivkovic, Karsten Schmidt, Thorsten Brenner, 2022, Diagnostics.

Does the clinical experience of a tutor influence how students learn extended focused assessment with sonography for trauma: A randomized controlled trial

A. Ruhparwar, F. Herbstreit, S. Shehada, 2022, Medical teacher.

Differential Regulation of CD45 Expression on Granulocytes, Lymphocytes, and Monocytes in COVID-19

K. Fares, S. Mohamed, A. Limmer, 2022, Journal of clinical medicine.

In-hospital and 6-month outcomes in patients with COVID-19 supported with extracorporeal membrane oxygenation (EuroECMO-COVID): a multicentre, prospective observational study

A. Nini, L. Fuchs, J. Maessen, 2022, The Lancet Respiratory Medicine.

Elevated Pre- and Postoperative ROTEM™ Clot Lysis Indices Indicate Reduced Clot Retraction and Increased Mortality in Patients Undergoing Liver Transplantation

F. Saner, M. Hartmann, Thorsten Brenner, 2022, Biomedicines.

Biomarkers extracted by fully automated body composition analysis from chest CT correlate with SARS-CoV-2 outcome severity

F. Nensa, J. Kleesiek, Sven Koitka, 2022, Scientific Reports.

Effect of Dexamethasone on the Incidence and Outcome of COVID-19 Associated Pulmonary Aspergillosis (CAPA) in Critically Ill Patients during First- and Second Pandemic Wave—A Single Center Experience

F. Herbstreit, H. Verhasselt, P. Rath, 2022, Diagnostics.

The Distinctive Activation of Toll-Like Receptor 4 in Human Samples with Sepsis

A. Zarbock, B. Koos, M. Adamzik, 2022, Cells.

Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients

O. Witzke, A. Krawczyk, U. Dittmer, 2022, Journal of clinical medicine.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

Anesthetic Management during Robotic-Assisted Minimal Invasive Thymectomy Using the Da Vinci System: A Single Center Experience

A. Ruhparwar, S. Shehada, M. Hochreiter, 2022, Journal of Clinical Medicine.

Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State

T. Vogl, J. Roth, A. Limmer, 2023, Vaccines.

Increased Enzymatic Activity of Acetylcholinesterase Indicates the Severity of the Sterile Inflammation and Predicts Patient Outcome following Traumatic Injury

M. Weigand, Aleksandar R. Zivkovic, S. Hofer, 2023, Biomolecules.

ECMO for COVID-19 patients in Europe and Israel

P. Leprince, M. Antonelli, H. Thiele, 2021, Intensive Care Medicine.

Identification of two early blood biomarkers ACHE and CLEC12A for improved risk stratification of critically ill COVID-19 patients

Y. Vainshtein, M. Manoochehri, K. Sohn, 2023, Scientific Reports.

The prevalence of sepsis-induced coagulopathy in patients with sepsis – a secondary analysis of two German multicenter randomized controlled trials

J. Briegel, P. Meybohm, G. Elke, 2023, Annals of Intensive Care.

Early Treatment with Monoclonal Antibodies or Convalescent Plasma Reduces Mortality in Non-Vaccinated COVID-19 High-Risk Patients

O. Witzke, P. Horn, A. Krawczyk, 2022, Viruses.

suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury

M. Zeier, E. Hahm, U. Merle, 2023, JCI insight.

Targeting the Granulocytic Defense against A. fumigatus in Healthy Volunteers and Septic Patients

P. Rath, Thorsten Brenner, L. Kirchhoff, 2023, International journal of molecular sciences.

Non-Neuronal Acetylcholinesterase Activity Shows Limited Utility for Early Detection of Sepsis

Aleksandar R. Zivkovic, S. Hofer, S. Decker, 2023, Biomedicines.

The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity

U. Stervbo, N. Babel, T. Westhoff, 2020, medRxiv.

Impact of Invasive Pulmonary Aspergillosis in Critically Ill Surgical Patients with or without Solid Organ Transplantation

F. Rengier, P. Schnitzler, C. Lichtenstern, 2023, Journal of clinical medicine.

Mapping the human genetic architecture of COVID-19

Mattia G. Bergomi, Christopher M. DeBoever, Matthew A. Wiles, 2021, Nature.

New susceptibility loci for severe COVID-19 by detailed GWAS analysis in European populations

M. Nöthen, S. Brunak, V. Moreno, 2021, medRxiv.

A second update on mapping the human genetic architecture of COVID-19

M. A. Hakim Newton, Jack D. Sanders, Jonathan H. Morgan, 2022, Nature.

Impact of low eGFR on the immune response against COVID-19

M. Or-Guil, U. Stervbo, N. Babel, 2022, Journal of Nephrology.

Generation of potentially inhibitory autoantibodies to ADAMTS13 in coronavirus disease 2019

U. Stervbo, N. Babel, T. Westhoff, 2023, Scientific reports.

Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.

M. Totzeck, T. Rassaf, F. Al-Rashid, 2023, International journal of cardiology.

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients

F. Heinemann, O. Witzke, P. Horn, 2021, Transfusion.

Serum KL-6 as a Candidate Predictor of Outcome in Patients with SARS-CoV-2 Pneumonia

F. Herbstreit, S. Sutharsan, M. Berger, 2023, Journal of clinical medicine.

Detailed stratified GWAS analysis for severe COVID-19 in four European populations

M. Buti, J. Barretina, P. Rosenstiel, 2022, Human Molecular Genetics.